Nocturia News and Research

RSS
AUA experts urge to focus on urologic health conditions in upcoming year

AUA experts urge to focus on urologic health conditions in upcoming year

Most Canadians hope OAB symptoms will go away

Most Canadians hope OAB symptoms will go away

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

Tru-flo urinary catheter valve from ProtekMed

Tru-flo urinary catheter valve from ProtekMed

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Significantly increased mortality rate in elderly patients with nocturia

Significantly increased mortality rate in elderly patients with nocturia

Increased mortality linked to frequent nightime urination

Increased mortality linked to frequent nightime urination

Bladder conditions - raising awareness

Bladder conditions - raising awareness

Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladder

Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladder

Coping with urinary incontinence

Coping with urinary incontinence

Placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms

Placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms

Prevalence of overactive bladder overestimated

Prevalence of overactive bladder overestimated

Do symptoms correlate with cystoscopic findings in newly diagnosed PBS/IC?

Do symptoms correlate with cystoscopic findings in newly diagnosed PBS/IC?

Alfuzosin may improve double-J stent related symptoms

Alfuzosin may improve double-J stent related symptoms